What You Should Know:
– Jerusalem-based Salignostics, a company specializing in rapid tests using saliva samples, has joined forces with ARC Innovation, the innovation arm of Sheba Medical Center, in a groundbreaking initiative.
– The strategic…
Continue Reading
Table of Contents
Introduction
Leadership Transition at ScreenPoint Medical
Vision and Expectations Under New Leadership
Impact on Breast Cancer Detection Technology
Reactions and Endorsements
FAQs
Introduction
ScreenPoint Medical, a leading provider of artificial intelligence (AI) solutions for breast cancer detection, has recently…
What You Should Know:
– Blue Earth Diagnostics, a Bracco company and leader in innovative PET radiopharmaceuticals, announced a data-sharing agreement with Siemens Healthineers.
– This collaboration focuses on anonymized data from Blue Earth’s Phase 3…
Continue Reading
What You Should Know:
– AccessHope, a company revolutionizing how cancer patients receive cutting-edge treatment plans secures $33M in a Series B funding round led by City of Hope, a prominent cancer research and treatment…
Continue Reading
What You Should Know:
Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that…
Continue Reading
What You Should Know:
Viome, a leading innovator of health technology and personalized health solutions, is partnering with Henry Schein to provide better access to Viome’s Oral Health Pro™ With CancerDetect™.Viome’s laboratory-developed test helps detect early…
Continue Reading
What You Should Know:
– GE HealthCare, a leader in ultrasound-guided urology solutions, has announced the launch of Prostate Volume Assist (PVA).
– The AI-powered solution is designed to empower urologists with faster and more efficient…
Continue Reading
iCAD introduces advanced features to streamline mammogram interpretation, enhancing radiologists’ efficiency and interpretability. The new capabilities include limiting lesion marks, color-coding abnormalities, and providing customizable score ranges. These enhancements aim to improve the readability…
Continue Reading
What You Should Know:
– Lunit (KRX:328130.KQ), a provider of AI-powered cancer diagnostics and therapeutics solutions, announced today two significant commercial agreements that mark its continued European expansion.
– These strategic deals will bring Lunit’s AI-powered…
Continue Reading
Transforming breast cancer detection, ScreenPoint Medical’s Transpara Breast AI integrates seamlessly into Johns Hopkins Medicine’s renowned breast imaging services. This collaboration harnesses cutting-edge technology and clinical expertise to enhance screening accuracy and patient outcomes….
Continue Reading
